Let us delve into some of the TLR agonists in the clinic and why the careful selection of these drugs is crucial.

A new drug application seeking the approval of ziftomenib was submitted to the FDA on April 8, 2025. This indication is for ...

This is being tested in the phase 1a/1b DIONE-01 study, which consists of parallel cohorts including uveal melanoma, and has completed the dose escalation phase testing safety and tolerability.

Q1 2025 Earnings Call Transcript May 1, 2025 Moderna, Inc. beats earnings expectations. Reported EPS is $-2.52, expectations were $-2.92. Operator: Good day, and thank you for standing by. Welcome to ...

Results published in the peer-reviewed journal Investigational New DrugsStudy in heavily pre-treated patients with solid tumor indications ...

all of the patients in the third study analysis with a low-risk DecisionDx-Melanoma test result (Class 1A) were recur It is hard to get excited after looking at Castle Biosciences' (NASDAQ ...

Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ETCompany ParticipantsLavina Talukdar - Senior Vice President, ...

The field of peptide research in animal health has witnessed remarkable advancements in recent years, offering promising ...

MAY IS OCULAR MELANOMA AWARENESS MONTH, AND A LOCAL ORGANIZATION IS STEPPING UP TO FIGHT THIS RARE CANCER THAT AFFECTS ABOUT 25,000, 2500 PEOPLE EACH. AND EVERY YEAR. A RUN WALK IS TAKING PLACE IN ...

Skin cancer is the most common malignancy in the US, with rising incidence rates, particularly among women and older adults. UV exposure counseling can enhance sun protection behaviors ...

With vibrant red hair, pale skin and lots of freckles, Sara McOlvin knew she was vulnerable to skin cancer, but there were even more risk factors to consider. Melanoma runs on both sides of her ...